MYRIAD GENETICS, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $771.4M | $753.8M | $723.1M | $778.2M | $613.2M | $496.0M | $402.1M | $362.6M |
| Cost of Revenue | $145.2M | $132.8M | $132.8M | $96.1M | $64.4M | $51.5M | $45.6M | $44.3M |
| Gross Profit | $626.2M | $621.0M | $590.3M | $682.1M | $548.8M | $444.6M | $356.4M | $318.4M |
| Gross Margin | 81.2% | 82.4% | 81.6% | 87.7% | 89.5% | 89.6% | 88.6% | 87.8% |
| Operating Expenses | ||||||||
| Research & Development | $74.4M | $70.6M | $75.5M | $67.5M | $53.7M | $42.6M | $27.8M | $21.9M |
| SG&A Expense | $439.9M | $359.2M | $366.0M | $327.1M | $251.8M | $208.4M | $169.8M | $161.4M |
| Operating Income | $44.0M | $153.4M | $133.6M | $274.4M | $228.0M | $180.3M | $157.8M | $135.1M |
| Operating Margin | 5.7% | 20.4% | 18.5% | 35.3% | 37.2% | 36.4% | 39.2% | 37.2% |
| Interest Expense | $6.0M | $300.0K | $200.0K | — | — | — | — | — |
| Pretax Income | $36.2M | $156.0M | $134.3M | $277.8M | $233.3M | $184.5M | $159.7M | $140.8M |
| Income Tax Expense | $19.0M | $38.8M | $54.5M | $101.6M | $86.1M | $72.4M | $58.9M | $-11.5M |
| Net Income | $17.4M | $117.2M | $79.8M | $176.2M | $147.2M | $112.2M | $100.7M | $152.3M |
| Net Margin | 2.3% | 15.5% | 11.0% | 22.6% | 24.0% | 22.6% | 25.0% | 42.0% |
| EPS (Basic) | $0.25 | $1.67 | $1.12 | $2.33 | $1.82 | $1.33 | $1.12 | $1.58 |
| EPS (Diluted) | $0.25 | $1.60 | $1.07 | $2.25 | $1.77 | $1.30 | $1.10 | $1.54 |
| Shares Outstanding (Basic) | 68.3M | 70.0M | 71.3M | 75.7M | 80.9M | 84.6M | 89.8M | 96.3M |
| Shares Outstanding (Diluted) | 68.8M | 73.4M | 74.5M | 78.2M | 83.3M | 86.5M | 91.7M | 99.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |